These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 38434180)
21. In vitro and in vivo drug release and antibacterial properties of the novel vancomycin-loaded bone-like hydroxyapatite/poly amino acid scaffold. Cao Z; Jiang D; Yan L; Wu J Int J Nanomedicine; 2017; 12():1841-1851. PubMed ID: 28331309 [TBL] [Abstract][Full Text] [Related]
22. Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Marriott I; Gray DL; Rati DM; Fowler VG; Stryjewski ME; Levin LS; Hudson MC; Bost KL Bone; 2005 Oct; 37(4):504-12. PubMed ID: 16027056 [TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944 [TBL] [Abstract][Full Text] [Related]
25. EGFR/FAK and c-Src signalling pathways mediate the internalisation of Staphylococcus aureus by osteoblasts. Ji Z; Su J; Hou Y; Yao Z; Yu B; Zhang X Cell Microbiol; 2020 Oct; 22(10):e13240. PubMed ID: 32584493 [TBL] [Abstract][Full Text] [Related]
26. Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis. Saidykhan L; Abu Bakar MZ; Rukayadi Y; Kura AU; Latifah SY Int J Nanomedicine; 2016; 11():661-73. PubMed ID: 26929622 [TBL] [Abstract][Full Text] [Related]
27. Staphylococcus aureus internalization impairs osteoblastic activity and early differentiation process. Mouton W; Josse J; Jacqueline C; Abad L; Trouillet-Assant S; Caillon J; Bouvard D; Bouchet M; Laurent F; Diot A Sci Rep; 2021 Sep; 11(1):17685. PubMed ID: 34480054 [TBL] [Abstract][Full Text] [Related]
28. Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis. Zelmer AR; Nelson R; Richter K; Atkins GJ Bone Res; 2022 Aug; 10(1):53. PubMed ID: 35961964 [TBL] [Abstract][Full Text] [Related]
30. The P2X7 Receptor is an Important Regulator of Extracellular ATP Levels. Brandao-Burch A; Key ML; Patel JJ; Arnett TR; Orriss IR Front Endocrinol (Lausanne); 2012; 3():41. PubMed ID: 22654865 [TBL] [Abstract][Full Text] [Related]
31. Staphylococcus aureus Infection Induces the Production of the Neutrophil Chemoattractants CXCL1, CXCL2, CXCL3, CXCL5, CCL3, and CCL7 by Murine Osteoblasts. Sipprell SE; Johnson MB; Leach W; Suptela SR; Marriott I Infect Immun; 2023 Apr; 91(4):e0001423. PubMed ID: 36880752 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo osteogenic activity of the novel vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) scaffold. Cao Z; Jiang D; Yan L; Wu J J Biomater Appl; 2016 May; 30(10):1566-77. PubMed ID: 26686585 [TBL] [Abstract][Full Text] [Related]
33. Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis. Josse J; Velard F; Gangloff SC Front Cell Infect Microbiol; 2015; 5():85. PubMed ID: 26636047 [TBL] [Abstract][Full Text] [Related]
34. Treatment of experimental osteomyelitis by liposomal antibiotics. Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079 [TBL] [Abstract][Full Text] [Related]
35. Antibody-antibiotic conjugate targeted therapy for orthopedic implant-associated intracellular S. aureus infections. Qin L; Hu N; Zhang Y; Yang J; Zhao L; Zhang X; Yang Y; Zhang J; Zou Y; Wei K; Zhao C; Li Y; Zeng H; Huang W; Zou Q J Adv Res; 2023 Dec; ():. PubMed ID: 38048846 [TBL] [Abstract][Full Text] [Related]
36. A Human Osteocyte Cell Line Model for Studying Gunn NJ; Zelmer AR; Kidd SP; Solomon LB; Roscioli E; Yang D; Atkins GJ Front Cell Infect Microbiol; 2021; 11():781022. PubMed ID: 34805001 [TBL] [Abstract][Full Text] [Related]
37. Tailored therapeutic release from polycaprolactone-silica hybrids for the treatment of osteomyelitis: antibiotic rifampicin and osteogenic silicates. Gritsch L; Granel H; Charbonnel N; Jallot E; Wittrant Y; Forestier C; Lao J Biomater Sci; 2022 Apr; 10(8):1936-1951. PubMed ID: 35258044 [TBL] [Abstract][Full Text] [Related]
38. Rifampicin restores extracellular organic matrix formation and mineralization of osteoblasts after intracellular Alagboso FI; Mannala GK; Walter N; Docheva D; Brochhausen C; Alt V; Rupp M Bone Joint Res; 2022 May; 11(5):327-341. PubMed ID: 35604422 [TBL] [Abstract][Full Text] [Related]